Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AccurEdit Therapeutics' LNP-based In Vivo Gene Editing Product ART001 Obtained Orphan Drug Designation from the FDA 2025-03-25 19:00
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer 2025-03-25 19:00
WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 2025-03-25 18:30
Medit Launches Medit i900 classic, a New Addition to Medit i900 Family Line Up 2025-03-25 15:00
WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024 2025-03-24 22:45
Sermonix and Regor Announce Strategic Collaboration to Optimize Regor's Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics 2025-03-24 22:30
Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval 2025-03-24 21:00
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025 2025-03-24 20:30
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS 2025-03-24 20:00
Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation 2025-03-24 11:00
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer 2025-03-24 08:15
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019 2025-03-24 07:56
Aphranel® MagiCCrystal CaHA Filler from Shanghai MOYOM Biotec, Obtains NMPA Class III Medical Device Certificate in China 2025-03-21 21:00
Syneron Bio Announces Strategic Collaboration with AstraZeneca 2025-03-21 20:02
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies 2025-03-21 19:21
Akeso's Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting 2025-03-21 11:14
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year 2025-03-21 08:30
Wounds hard to heal? Troubled by dressing changes? Dimora, Amazon's 3-year top brand, shows you the way. 2025-03-21 01:08
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025 2025-03-21 00:00
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025 2025-03-20 21:00